Porcine circovirus, porcine pseudorabies virus and mycoplasma triple inactivated vaccine

A porcine pseudorabies virus, porcine circovirus technology, applied in the direction of virus antigen components, virus/phage, vaccines, etc., can solve the problems of high immunization frequency, easy recurrence, pig stress, etc., to simplify the immunization program, reduce The probability of side effects of vaccines and the effect of reducing the cost of epidemic prevention

Pending Publication Date: 2021-06-15
JIANGXI ZHENGBANG TECHNOLOGY CO LTD +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Mycoplasma pneumonia in swine is a stubborn chronic disease. Anti-mycoplasma drug treatment can generally suppress the disease but it is difficult to clear it up. The symptoms of cough and asthma disappear after the drug is stopped, but it is easy to recur after stopping the drug.
[0005] At present, there are only related single vaccines or dual vaccines in the commercially available vaccines, and the frequency of immunization is too high, which leads to stress in pigs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The invention provides a technical scheme: porcine circovirus, porcine pseudorabies virus and mycoplasma triple inactivated vaccine, including antigen and vaccine adjuvant, and the antigen is composed of porcine circovirus type 2 antigen, porcine pseudorabies virus antigen and mycoplasma Antigen composition, the porcine circovirus type 2 antigen is purified, concentrated and inactivated porcine circovirus type 2 protein antigen solution, and the Cap protein content is ≥ 160 μg / ml; the porcine pseudorabies virus antigen is purified, concentrated and inactivated The porcine pseudorabies virus protein antigen solution, the Cap protein content is ≥ 160 μg / ml; the mycoplasma antigen is an inactivated mycoplasma protein antigen solution, and the Cap protein content is ≥ 160 μg / ml; the vaccine adjuvant is composed of a water-based polymer agent and compound polysaccharide immune enhancer.

[0030] In this embodiment, preferably, the water-based polymer adjuvant is Montanide Ge...

Embodiment 2

[0047] The invention provides a technical scheme: porcine circovirus, porcine pseudorabies virus and mycoplasma triple inactivated vaccine, including antigen and vaccine adjuvant, and the antigen is composed of porcine circovirus type 2 antigen, porcine pseudorabies virus antigen and mycoplasma Antigen composition, the porcine circovirus type 2 antigen is purified, concentrated and inactivated porcine circovirus type 2 protein antigen solution, and the Cap protein content is ≥ 160 μg / ml; the porcine pseudorabies virus antigen is purified, concentrated and inactivated The porcine pseudorabies virus protein antigen solution, the Cap protein content is ≥ 160 μg / ml; the mycoplasma antigen is an inactivated mycoplasma protein antigen solution, and the Cap protein content is ≥ 160 μg / ml; the vaccine adjuvant is composed of a water-based polymer agent and compound polysaccharide immune enhancer.

[0048] In this embodiment, preferably, the water-based polymer adjuvant is Montanide Ge...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a porcine circovirus, porcine pseudorabies virus and mycoplasma triple inactivated vaccine which comprises an antigen and a vaccine adjuvant, the antigen is composed of a porcine circovirus type 2 antigen, a porcine pseudorabies virus antigen and a mycoplasma antigen, the porcine circovirus type 2 antigen is a purified, concentrated and inactivated porcine circovirus type 2 protein antigen solution, and the content of Cap protein is more than or equal to 160 [mu]g/ml; the porcine pseudorabies virus antigen is a purified, concentrated and inactivated porcine pseudorabies virus protein antigen solution, and the content of the Cap protein is more than or equal to 160 [mu]g/ml; the mycoplasma antigen is an inactivated mycoplasma protein antigen solution, and the content of the Cap protein is more than or equal to 160 [mu]g/ml; and the vaccine adjuvant is composed of a water-based high-molecular polymer adjuvant and a composite polysaccharide immunopotentiator. Foreign protein is removed through clarification filtration and ultrafiltration concentration, and the side reaction probability of the vaccine is greatly reduced; and three-proofing can be achieved through one needle, so that the number of immunization times and stress are reduced. The method is economical and practical, the immunization procedure is simplified, and the epidemic prevention cost is reduced.

Description

technical field [0001] The invention relates to the technical field of veterinary biological products, in particular to a triple inactivated vaccine of porcine circovirus, porcine pseudorabies virus and mycoplasma. Background technique [0002] Porcine circovirus disease is an infectious disease of pigs caused by porcine circovirus type 2, which causes piglet weaning syndrome, porcine dermatitis and nephrotic syndrome, and reproductive disorders in sows. Its clinical manifestations are diverse. After pigs are infected with circovirus, it can cause severe immunosuppression, resulting in secondary or concurrent other infectious diseases, such as mycoplasma, Haemophilus parasuis, Streptococcus suis and other diseases. [0003] Pseudorabies is an acute infectious disease caused by pseudorabies virus (Pseudorabiesvirus, PRV), including a variety of livestock and wild animals. Pigs are the natural host and reservoir of the disease virus. The disease is characterized by fever, sev...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/295A61K39/12A61K39/245A61K39/02A61K39/39A61P31/22A61P31/20A61P31/04C07K14/01C07K14/03C07K14/30C07K1/14
CPCA61K39/12A61K39/0241A61K39/39A61P31/22A61P31/20A61P31/04C07K14/005C12N2710/16722C12N2750/10022C12N2750/10034C12N2710/16734A61K2039/70A61K2039/5252A61K2039/552A61K2039/521A61K2039/55583
Inventor 王闯林峰肖敏任华花纪
Owner JIANGXI ZHENGBANG TECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products